Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients

Melanie C. Dispenza, Ellen B. Wolpert, Kathryn L. Gilliland, Jenny P. Dai, Zhaoyuan Cong, Amanda M. Nelson, Diane M. Thiboutot

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Retinoids are used in the treatment of inflammatory skin diseases and malignancies, but studies characterizing the in vivo actions of these drugs in humans are lacking. Isotretinoin is a pro-drug for all-trans retinoic acid, which can induce long-term remissions of acne; however, its complete mechanism of action is unknown. We hypothesized that isotretinoin induces remission of acne by normalizing the innate immune response to the commensal bacterium Propionibacterium acnes. Compared with normal subjects, peripheral blood monocytes from acne patients expressed significantly higher levels of Toll-like receptor 2 (TLR-2) and exhibited significantly greater induction of TLR-2 expression following P. acnes stimulation. Treatment of patients with isotretinoin significantly decreased monocyte TLR-2 expression and subsequent inflammatory cytokine response to P. acnes after 1 week of therapy. This effect was sustained 6 months following cessation of therapy, indicating that TLR-2 modulation may be involved in the durable therapeutic response to isotretinoin. This study demonstrates that isotretinoin exerts immunomodulatory effects in patients and sheds light on a potential mechanism for its long-term effects on acne. The modulation of TLR-2 expression on monocytes has important implications in other inflammatory disorders characterized by TLR-2 dysregulation.

Original languageEnglish (US)
Pages (from-to)2198-2205
Number of pages8
JournalJournal of Investigative Dermatology
Volume132
Issue number9
DOIs
StatePublished - Jan 1 2012

Fingerprint

Toll-Like Receptor 2
Isotretinoin
Acne Vulgaris
Innate Immunity
Propionibacterium acnes
Monocytes
Therapeutics
Modulation
Retinoids
Prodrugs
Tretinoin
Skin Diseases
Bacteria
Skin
Blood
Cytokines
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Dispenza, Melanie C. ; Wolpert, Ellen B. ; Gilliland, Kathryn L. ; Dai, Jenny P. ; Cong, Zhaoyuan ; Nelson, Amanda M. ; Thiboutot, Diane M. / Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. In: Journal of Investigative Dermatology. 2012 ; Vol. 132, No. 9. pp. 2198-2205.
@article{a14acb5c0eca45d4990afe8e9724d448,
title = "Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients",
abstract = "Retinoids are used in the treatment of inflammatory skin diseases and malignancies, but studies characterizing the in vivo actions of these drugs in humans are lacking. Isotretinoin is a pro-drug for all-trans retinoic acid, which can induce long-term remissions of acne; however, its complete mechanism of action is unknown. We hypothesized that isotretinoin induces remission of acne by normalizing the innate immune response to the commensal bacterium Propionibacterium acnes. Compared with normal subjects, peripheral blood monocytes from acne patients expressed significantly higher levels of Toll-like receptor 2 (TLR-2) and exhibited significantly greater induction of TLR-2 expression following P. acnes stimulation. Treatment of patients with isotretinoin significantly decreased monocyte TLR-2 expression and subsequent inflammatory cytokine response to P. acnes after 1 week of therapy. This effect was sustained 6 months following cessation of therapy, indicating that TLR-2 modulation may be involved in the durable therapeutic response to isotretinoin. This study demonstrates that isotretinoin exerts immunomodulatory effects in patients and sheds light on a potential mechanism for its long-term effects on acne. The modulation of TLR-2 expression on monocytes has important implications in other inflammatory disorders characterized by TLR-2 dysregulation.",
author = "Dispenza, {Melanie C.} and Wolpert, {Ellen B.} and Gilliland, {Kathryn L.} and Dai, {Jenny P.} and Zhaoyuan Cong and Nelson, {Amanda M.} and Thiboutot, {Diane M.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1038/jid.2012.111",
language = "English (US)",
volume = "132",
pages = "2198--2205",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "9",

}

Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. / Dispenza, Melanie C.; Wolpert, Ellen B.; Gilliland, Kathryn L.; Dai, Jenny P.; Cong, Zhaoyuan; Nelson, Amanda M.; Thiboutot, Diane M.

In: Journal of Investigative Dermatology, Vol. 132, No. 9, 01.01.2012, p. 2198-2205.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients

AU - Dispenza, Melanie C.

AU - Wolpert, Ellen B.

AU - Gilliland, Kathryn L.

AU - Dai, Jenny P.

AU - Cong, Zhaoyuan

AU - Nelson, Amanda M.

AU - Thiboutot, Diane M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Retinoids are used in the treatment of inflammatory skin diseases and malignancies, but studies characterizing the in vivo actions of these drugs in humans are lacking. Isotretinoin is a pro-drug for all-trans retinoic acid, which can induce long-term remissions of acne; however, its complete mechanism of action is unknown. We hypothesized that isotretinoin induces remission of acne by normalizing the innate immune response to the commensal bacterium Propionibacterium acnes. Compared with normal subjects, peripheral blood monocytes from acne patients expressed significantly higher levels of Toll-like receptor 2 (TLR-2) and exhibited significantly greater induction of TLR-2 expression following P. acnes stimulation. Treatment of patients with isotretinoin significantly decreased monocyte TLR-2 expression and subsequent inflammatory cytokine response to P. acnes after 1 week of therapy. This effect was sustained 6 months following cessation of therapy, indicating that TLR-2 modulation may be involved in the durable therapeutic response to isotretinoin. This study demonstrates that isotretinoin exerts immunomodulatory effects in patients and sheds light on a potential mechanism for its long-term effects on acne. The modulation of TLR-2 expression on monocytes has important implications in other inflammatory disorders characterized by TLR-2 dysregulation.

AB - Retinoids are used in the treatment of inflammatory skin diseases and malignancies, but studies characterizing the in vivo actions of these drugs in humans are lacking. Isotretinoin is a pro-drug for all-trans retinoic acid, which can induce long-term remissions of acne; however, its complete mechanism of action is unknown. We hypothesized that isotretinoin induces remission of acne by normalizing the innate immune response to the commensal bacterium Propionibacterium acnes. Compared with normal subjects, peripheral blood monocytes from acne patients expressed significantly higher levels of Toll-like receptor 2 (TLR-2) and exhibited significantly greater induction of TLR-2 expression following P. acnes stimulation. Treatment of patients with isotretinoin significantly decreased monocyte TLR-2 expression and subsequent inflammatory cytokine response to P. acnes after 1 week of therapy. This effect was sustained 6 months following cessation of therapy, indicating that TLR-2 modulation may be involved in the durable therapeutic response to isotretinoin. This study demonstrates that isotretinoin exerts immunomodulatory effects in patients and sheds light on a potential mechanism for its long-term effects on acne. The modulation of TLR-2 expression on monocytes has important implications in other inflammatory disorders characterized by TLR-2 dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=84865313629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865313629&partnerID=8YFLogxK

U2 - 10.1038/jid.2012.111

DO - 10.1038/jid.2012.111

M3 - Article

C2 - 22513780

AN - SCOPUS:84865313629

VL - 132

SP - 2198

EP - 2205

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 9

ER -